Efficacy and safety of Changyanning tablets in the treatment of diarrhea-predominant irritable bowel syndrome and its effect on gut microbiota：Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Yanran Ban(Wangjing Hospital of China Academy of Chinese Medical Sciences), Wei Wei(Nanchang University), Ling He(Hunan University), Danping Qin(Zhejiang Chinese Medical University), Wang-li Cao(Zhejiang Pharmaceutical College), Wenxia Zhao(First Affiliated Hospital of Henan University), Yanping Tang(Zhujiang Hospital), Xiaoyan Wang(Central South University), Yang Yang(Fujian University of Traditional Chinese Medicine), Kaixuan Zhang(Beijing University of Technology), Ningjuan Yan(Wangjing Hospital of China Academy of Chinese Medical Sciences), Qian Yang, Shun-ping Ren(Shanxi University), Lu-zhou Xu(Nanjing University of Chinese Medicine), Endian Zheng(Wenzhou City People's Hospital), Chengdang Wang, Li-mei Zheng(Gaozhou People's Hospital), Beiping Zhang(Guangzhou University of Chinese Medicine)
Cited by 0
Related Papers
Structure-based classification of tauopathies
|Nature|2021|916
Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats
|Journal of Ethnopharmacology|2006|272
Efficacy of Thalidomide for Refractory Gastrointestinal Bleeding From Vascular Malformation
|Gastroenterology|2011|231